Novavax Inc (NVAX)

17.32
+0.10(+0.58%)
Pre Market
17.30
-0.02(-0.12%)
- Real-time Data
  • Volume:
    3,875,403
  • Day's Range:
    16.40 - 17.82
  • 52 wk Range:
    15.53 - 236.50

NVAX Overview

Prev. Close
17.22
Day's Range
16.4-17.82
Revenue
1.8B
Open
17.27
52 wk Range
15.53-236.5
EPS
-17.14
Volume
3,875,403
Market Cap
1.36B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
5,043,011
P/E Ratio
-0.965
Beta
1.89
1-Year Change
-90.47%
Shares Outstanding
78,503,952
Next Earnings Date
Feb 26, 2023
What is your sentiment on Novavax?
or
Market is currently closed. Voting is open during market hours.

Novavax Inc News

Novavax Inc Analysis

Novavax Inc Company Profile

Novavax Inc Company Profile

Employees
1541

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong SellStrong Sell